Brain Pathology in Multiple Sclerosis with High-Field-Strength MR Spectroscopic Imaging
- PMID: 34981980
- PMCID: PMC8961717
- DOI: 10.1148/radiol.212026
Brain Pathology in Multiple Sclerosis with High-Field-Strength MR Spectroscopic Imaging
Conflict of interest statement
Figures

Comment on
-
Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.Radiology. 2022 Apr;303(1):141-150. doi: 10.1148/radiol.210614. Epub 2022 Jan 4. Radiology. 2022. PMID: 34981978
References
-
- Thompson AJ , Banwell BL , Barkhof F , et al. . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria . Lancet Neurol 2018. ; 17 ( 2 ): 162 – 173 . - PubMed
-
- Wattjes MP , Ciccarelli O , Reich DS , et al. . 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis . Lancet Neurol 2021. ; 20 ( 8 ): 653 – 670 . - PubMed
-
- Arnold DL , Matthews PM , Francis G , Antel J . Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease . Magn Reson Med 1990. ; 14 ( 1 ): 154 – 159 . - PubMed
-
- De Stefano N , Filippi M , Miller D , et al. . Guidelines for using proton MR spectroscopy in multicenter clinical MS studies . Neurology 2007. ; 69 ( 20 ): 1942 – 1952 . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical